Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin: Complete Statistical AnalysisIndependent statistical analysis of Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03296033).
- Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: Complete Statistical AnalysisIndependent statistical analysis of Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RESISTIndependent statistical analysis of Aspirin Resistance and Percutaneous Coronary Intervention (PCI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01103440).
- RESISTIndependent statistical analysis of Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03481777).
- ResistAZMIndependent statistical analysis of Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis: Complete Statistical AnalysisIndependent statistical analysis of Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01111305).
- RESOLVEIndependent statistical analysis of Tailored Non-Pharmacotherapy Services for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04523714).
- RESOLVE-ITIndependent statistical analysis of Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH): primary endpoint results, effect estimate with confidence interval, sample-size…
- Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00400153).
- Respiratory Capacity and Swallowing Function in Spinal Disorders: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Respiratory Capacity and Swallowing Function in Spinal Disorders: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Respiratory Muscle Training (RMT) in ALS: Complete Statistical AnalysisIndependent statistical analysis of Respiratory Muscle Training (RMT) in ALS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04224961).
- Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017): Complete Statistical AnalysisIndependent statistical analysis of Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region: Complete Statistical AnalysisIndependent statistical analysis of Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RESPIREIndependent statistical analysis of Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RespireIndependent statistical analysis of Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RESPIRE 1Independent statistical analysis of RESPIRE 1, a randomized phase 3 trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis, including time-to-exacerbation and exacerbation-rate analyses.
- RESPIRE 1Independent statistical analysis of Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Response of Alkylresorcinols to Different Cereals: Complete Statistical AnalysisIndependent statistical analysis of Response of Alkylresorcinols to Different Cereals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01287403).
- Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.: Complete Statistical AnalysisIndependent statistical analysis of Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Response to Diaphragmatic Pacing in Subjects With Pompe Disease: Complete Statistical AnalysisIndependent statistical analysis of Response to Diaphragmatic Pacing in Subjects With Pompe Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354651).
- Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema: Complete Statistical AnalysisIndependent statistical analysis of Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01238822).
- Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03789240).
- Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS): Complete Statistical AnalysisIndependent statistical analysis of Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831934).
- Responses to Message Source and Presentation Using Psychophysiology: Complete Statistical AnalysisIndependent statistical analysis of Responses to Message Source and Presentation Using Psychophysiology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06269003).
- Responses to Rabies Vaccine in Adults With or Without Antibiotics: Complete Statistical AnalysisIndependent statistical analysis of Responses to Rabies Vaccine in Adults With or Without Antibiotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557008).
- Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101): Complete Statistical AnalysisIndependent statistical analysis of Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101): primary endpoint results, effect estimate with confidence interval,…
- RESTIndependent statistical analysis of A Study to Evaluate the Safety, Tolerability and Effectiveness of the Renew Insert in Treating Accidental Bowel Leakage: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RESTIndependent statistical analysis of Relationship of Exercise, Sleep, and Inflammation Markers in People Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REST-ITIndependent statistical analysis of Reducing Suicidal Ideation Through Insomnia Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689909).
- Restasis for Treatment of Brittle Nails: Complete Statistical AnalysisIndependent statistical analysis of Restasis for Treatment of Brittle Nails: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00986427).
- RESTINGIndependent statistical analysis of The RESTING Insomnia Study: Randomized Controlled Study on Effectiveness of Stepped-Care Sleep Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Resting-State Neural Connectivity in Patients With Subjective Tinnitus Without Bother: Complete Statistical AnalysisIndependent statistical analysis of Resting-State Neural Connectivity in Patients With Subjective Tinnitus Without Bother: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01049828).
- RestorAATion-1Independent statistical analysis of A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1): primary endpoint results, effect estimate with confidence…
- Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Restoration® Modular Revision Hip System Post Market Study: Complete Statistical AnalysisIndependent statistical analysis of Restoration® Modular Revision Hip System Post Market Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00962013).
- RESTOREIndependent statistical analysis of A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24…
- RESTOREIndependent statistical analysis of A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RestoreIndependent statistical analysis of RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02090114).
- ReSTOREIndependent statistical analysis of Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RESTOREIndependent statistical analysis of Restorative Exercise for Strength Training and Operational Resilience (RESTORE) for Chronic or Recurrent Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- RESTORE-IMI 1Independent statistical analysis of Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RESTORE-MEIndependent statistical analysis of Effects of a Resistance Training Program in Older Women With Sarcopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RESTORE1Independent statistical analysis of Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03887429).
- Restoring High Dimensional Hand Function to Persons With Chronic High Tetraplegia: Complete Statistical AnalysisIndependent statistical analysis of Restoring High Dimensional Hand Function to Persons With Chronic High Tetraplegia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Restrictive Fluid Therapy in Severe Preeclampsia: Complete Statistical AnalysisIndependent statistical analysis of Restrictive Fluid Therapy in Severe Preeclampsia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02214186).
- Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…